EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Efficacy of Consistency Versus Switching of Biologics for Prevention of Postoperative Recurrence in Crohn’s Disease: A Multicenter Real-World Retrospective Study

Chunjie Zhang, Juan Wu, Zhaoxiu Liu, Leilei Luo, Wen Tang, Jing Sun, Fenfen Wang, Yan Chen iD, Yanjun Chen, Wei Han, Meijiao Lu, Zhaolian Bian und 5 weitere

Inflammatory Bowel Diseases · 2025

DOI: 10.1093/ibd/izaf299 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Chunjie Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Center for Inflammatory Bowel Diseases, Department of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, N…. Hauptthemen laut MEDLINE: Crohn Disease, Biological Products, Secondary Prevention, Postoperative Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jinling Hospital Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance In Crohn’s disease (CD) patients treated with biologics preoperatively, the optimal strategy for postoperative biologic management remains unclear.

Design

This was a retrospective multicenter study involving CD patients with ileocolonic anastomosis from 9 medical centers. Patients were divided into “the consistent group” (postoperative biologic previously used before surgery) and “the switched group” (postoperative biologic not used preoperatively). The primary endpoint was postoperative endoscopic recurrence (ER), which was defined as the first endoscopy performed between 6 and 18 months after surgery. Propensity score matching (PSM) was used to minimize baseline differences between groups, and conditional logistic regression was applied to identify factors associated with ER.

Results

In total, 227 patients were included in the study, of whom 177 were in the consistent group. No significant difference was observed in the rate of ER between the switched group and the consistent group (30.0% vs 40.7%, P = .170). In patients with ≤2 risk factors defined by established guidelines, the switched group showed a lower ER rate (20.6% vs 40.0%, P = .038). After 1:1 PSM, the switched group had a lower ER rate (29.4% vs 61.8%, P = .027). Conditional logistic regression analysis revealed that switching biologics was associated with a lower risk of ER (odds ratio = 0.31, 95% confidence interval, 0.11-0.85, P = .023).

Conclusions

In CD patients with preoperative biologic exposure, both continuing and switching biologic therapy postoperatively were effective in preventing ER, with switching showing improved endoscopic outcomes after adjustment for confounders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseBiological ProductsSecondary PreventionPostoperative ComplicationsDrug SubstitutionHumansRetrospective StudiesMaleFemaleAdultMiddle AgedRecurrencePropensity ScoreFollow-Up StudiesRisk FactorsYoung Adult

Stichwörter der Autor:innen

Crohn’s diseasebiologicsendoscopic recurrencepostoperative recurrence

Substanzen

Biological Products

Autor:innen und Institutionen

  • Center for Inflammatory Bowel Diseases, Department of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210002, China.
  • Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
  • Department of Gastroenterology, Affliated Hospital of Nantong University, Chongchuan District, Nantong, 226001, China.
  • Department of Gastroenterology and Hepatology, Nantong Third People's Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, Jiangsu, 226001, China.
  • Department of Gastroenterology and Hepatology, Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
  • Department of Gastroenterology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, 214000, China.

ORCID-Profile: Yan Chen, Yi Li

Förderung

  • National Natural Science Foundation of China
  • Jinling Hospital Fund

Zitieren

APA

Zhang, C., Wu, J., Liu, Z., Luo, L., Tang, W., Sun, J., Wang, F., Chen, Y., Chen, Y., Han, W., Lu, M., Bian, Z., Lu, C., Hu, N., Zhu, L., Liao, X., & Li, Y. (2025). Efficacy of Consistency Versus Switching of Biologics for Prevention of Postoperative Recurrence in Crohn’s Disease: A Multicenter Real-World Retrospective Study. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf299

Vancouver

Zhang C, Wu J, Liu Z, Luo L, Tang W, Sun J, et al. Efficacy of Consistency Versus Switching of Biologics for Prevention of Postoperative Recurrence in Crohn’s Disease: A Multicenter Real-World Retrospective Study. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izaf299

BibTeX
@article{Zhang2025,
  author = {Zhang, Chunjie and Wu, Juan and Liu, Zhaoxiu and Luo, Leilei and Tang, Wen and Sun, Jing and Wang, Fenfen and Chen, Yan and Chen, Yanjun and Han, Wei and Lu, Meijiao and Bian, Zhaolian and Lu, Cuihua and Hu, Naizhong and Zhu, Lanxiang and Liao, Xiujun and Li, Yi},
  title = {Efficacy of Consistency Versus Switching of Biologics for Prevention of Postoperative Recurrence in Crohn’s Disease: A Multicenter Real-World Retrospective Study},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  doi = {10.1093/ibd/izaf299}
}
Kostenlos starten →